ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS OR REGULATIONS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THIS AREA OF THE WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR TO BE ACCESSED BY PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH CONSENT OR OTHER FORMALITY WHICH SPIRE HEALTHCARE GROUP PLC REGARDS AS UNDULY ONEROUS.
PLEASE ENSURE YOU HAVE READ AND CONFIRMED YOUR UNDERSTANDING AND ACCEPTANCE OF THE DISCLAIMER.
Further extension to PUSU deadline (4 September 2026)
Further extension to PUSU deadline (3 September 2026)
Further extension of the PUSU deadline (21 August 2026)
Further extension of the PUSU deadline (6 August 2026)
Chair succession (14 July 2026)
Further extension to PUSU deadline (9 July 2026)
Further extension to PUSU deadline (25 June 2026)
Extension to PUSU deadline (11 June 2026)
Form 8 DD (J Ash) (19 May 2026)
Form 8 DD (H Samra) (19 May 2026)
Spire Healthcare AGM Trading Statement (14 May 2026)
Spire – possible offer announcement (14 May 2026)
Update on strategic review (20 March 2026)
Spire results for the year ended 31 December 2025 (5 March 2026)
Extension to PUSU deadline (18 February 2026)
Statement regarding media speculation (24 January 2026)
Spire Healthcare trading update (3 December 2025)
Rule 2.11 Letter to Shareholders (Hard Copy)
Rule 2.11 Letter to Shareholders (Website Notification)
Rule 2.11 Email to Shareholders (Website Notification)
Rule 2.11 Email to Optionholders (Website Notification)
Rule 2.11 Letter to Optionholders (Hard Copy)